© 2026 Sinochem Nanjing Corporation,
All Right Reserved
3-Hydroxy Cephalosporin stands as a vital intermediate within the cephalosporin antibiotic family, shaped by a defining β-lactam ring and a 3-hydroxy functional group on the core structure. This compound works as both a building block for advanced cephalosporin antibiotics and a raw material for further chemical synthesis. With a backbone closely resembling naturally occurring cephalosporins, this chemical secures its role in research and industry through structural stability and reactivity patterns essential for medicinal chemistry workflows.
Available as white to pale yellow crystalline powder, 3-Hydroxy Cephalosporin can present in various physical textures: powder, flakes, solid crystals, pearls, or occasionally reconstituted as a solution. Density settles between 1.3–1.45 g/cm³, reflecting a tightly bonded molecular structure. Melting point hovers around 170–200°C, indicating robust exposure resistance, meaning material does not readily break down under mild heat. Odor sits at negligible. Grain size can vary based on production methods—from fine powders employed in synthesis to larger flake form used for chemical manipulation.
Molecular structure revolves around the core cephalosporin scaffold, formula C15H14N4O6S2 for the standard variant. The presence of both an amide and a 3-hydroxy group shapes a molecule ready for further chemical modification. The molecule weighs approximately 410.43 g/mol, making it manageable for scale-up processes. Water solubility ranges from slight to moderate, with an ease of dispersion in polar solvents. This makes it well-suited as a starting material in large-scale fermentation or semi-synthetic pathways.
Most prominently, 3-Hydroxy Cephalosporin appears in pharmaceutical research, serving as a precursor for active compounds within the cephalosporin antibiotic class. Medicinal chemists often use it to introduce hydroxyl functionality at a reactive site, facilitating chemical diversification. Batch consistency brings steady properties to industrial production, translating to consistent yields in cephalosporin derivatization. Stability under ambient conditions, coupled with non-hygroscopic behavior, means lengthy storage is possible without significant loss of quality, something chemists depend on for multi-step synthesis.
Safe handling of 3-Hydroxy Cephalosporin requires protection from both skin and respiratory contact, as cephalosporin compounds have been known to provoke allergic reactions in sensitive workers. Dust particles may cause mild irritation to eyes, nose, or throat. For large-scale handling, appropriate gloves, goggles, and masking ensure protection. Material Safety Data Sheets rate this compound as hazardous for direct exposure, so lab environments must practice containment and dust control. HS Code for the material commonly lists under 29419090 (other heterocyclic compounds), relevant for global trade and regulatory compliance. Waste residues go for specialized disposal—never directed down common drains, since environmental persistence presents eco-toxicological risk.
The molecule's architecture, featuring the β-lactam nucleus and attached 3-hydroxy group, supports functionalization through acylation, condensation, and halogenation. These groups provide the leverage needed for researchers to build out side chains or modify activity in final drug molecules. Structure-activity relationship (SAR) studies often return to this compound as a control owing to its predictable behavior during synthetic derivatization. Salt forms may be prepared for custom solubility or stability needs, but the parent compound remains a go-to for most synthetic applications.
Standard quality grades focus on chemical purity above 98%, with water content below 1.5%. Particle size distribution is monitored to ensure reproducibility in both lab and kilo-lab settings. Analytical profiles via HPLC, NMR, and IR guarantee identity and exclude adulterants. Storage takes place in cool, dry areas, sealed against atmospheric moisture and light, citing chemical sensitivity to oxidative degradation. Shelf life often stretches past 24 months when following recommended storage protocols. Supply chain providers track source and batch integrity, supporting full traceability from raw material acquisition through final product shipment.
Molecular insight into 3-Hydroxy Cephalosporin showcases its place as a synthetic intersection—balancing the need for strong β-lactam activity with chemical flexibility. Researchers emphasize the demand for sustainable, efficient synthesis routes as the pharmaceutical market pushes for greener practices, aiming to replace hazardous reagents with environmentally safer alternatives. Approaches involving biocatalysis or solvent recycling present viable replacements for legacy processes, yet must maintain the stringent quality demands of this intermediate. The drive for high yield, low-waste synthesis remains a focal point, requiring cooperation between process chemists, regulatory bodies, and environmental specialists.
Hazards associated with 3-Hydroxy Cephalosporin reflect common concerns in the antibiotic intermediate sector—skin and inhalation sensitivities, chemical reactivity hazards, and environmental persistence. Mitigation strategies rest on proper training, tight procedural control, and investment in closed-system handling. Small research startups might find licensing, waste processing, and regulatory hurdles steep, so shared infrastructure and cooperative disposal programs could lower barriers. Chemical innovation—pushing toward less toxic synthesis and advanced purification—continues as a natural outcome of pharmaceutical industry responsibility. By building a robust information ecosystem, manufacturers and end-users ensure not only compliance, but also a health-forward approach in the development and application of 3-Hydroxy Cephalosporin and related compounds.
